Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Virtual Outreach: a randomised controlled trial and economic appraisal
ISRCTN ISRCTN54264250
ClinicalTrials.gov identifier
Public title Virtual Outreach: a randomised controlled trial and economic appraisal
Scientific title
Acronym N/A
Serial number at source HTA 96/02/05
Study hypothesis The project was designed to evaluate the feasibility of teleconferenced medical consultations (TMCs) at the interface between primary and secondary care. The key research objectives were:
1. To determine the views of specialists, GPs and patients about TMCs
2. To test the feasibility of TMCs
3. To determine which specialties are most suited to TMCs
4. To make plans for a randomised controlled trial of TMCs.
The key issues of interest related to the relative value of real time teleconferenced medical consultations (TMCs) as an alternative to routine outpatient referral. The study was designed to evaluate the potential of TMCs to improve patients¿ health and satisfaction, and to lead to more efficient usage of health service resources in terms of tests and investigations, procedures, operations and prescriptions. We were particularly interested to find out whether the joint consultations could reduce the number of outpatient and GP consultations following the index consultation. In addition, the study was designed to examine the educational and organisational impact of TMCs. The pilot study was carried out in order to test the feasibility of a full-scale trial. In particular we wished to find out whether we could recruit adequate numbers of patients, whether standard instruments could be used effectively to measure the key outcomes, and whether we would be able to measure the educational and organisational impact of introducing TMCs.
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Teleconferenced medical consultations
Participants - inclusion criteria All patients referred by the participating general practitioners for a hospital specialist opinion in the following specialty areas: ENT medicine, general medicine (including endocrinology and rheumatology), gastroenterology, orthopaedics, neurology and urology
Participants - exclusion criteria Not provided at time of registration.
Anticipated start date 01/06/1998
Anticipated end date 31/10/2001
Status of trial Completed
Patient information material
Target number of participants 2,094
Interventions Videoconference link (tele-consultation) versus routine hospital outpatients consultation
Primary outcome measure(s) The following instruments were used in the trial:
1. A patient demographic and personal details questionnaire
2. S F12 generic measure of well-being
3. Ware Specific Visit Questionnaire (SVQ) for patient satisfaction
4. Speiberger Standing State Anxiety Inventory (STAI)
5. A patient cost questionnaire
6. Duke Severity of Illness questionnaire (DUSOI) to measure the co-morbidity or burden of illness
7. Protocol specifically designed to extract data for hospital and GP records
Secondary outcome measure(s) Not provided at time of registration.
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 1. 2004 HTA monograph in http://www.ncbi.nlm.nih.gov/pubmed/15546515
3. 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12855528
4. 2002 main results in http://www.ncbi.nlm.nih.gov/pubmed/12076550
5. 2002 publication on design and performance of the trial in http://www.ncbi.nlm.nih.gov/pubmed/11835692
2. 2002 protocol in http://www.ncbi.nlm.nih.gov/pubmed/11835692
Contact name Prof  Paul  Wallace
  Address Department of Primary Care and Population Sciences
Royal Free and University College Medical School
Rowland Hill Street
  City/town London
  Zip/Postcode NW3 2PF
  Country United Kingdom
  Tel +44 (0)20 7830 2339
  Fax +44 (0)20 7830 2338
  Email p.wallace@pcps.ucl.ac.uk
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 09/01/2002
Last edited 25/08/2009
Date ISRCTN assigned 09/01/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central